These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H Mol Brain; 2012 May; 5():17. PubMed ID: 22613578 [TBL] [Abstract][Full Text] [Related]
4. HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity. Mattis VB; Tom C; Akimov S; Saeedian J; Østergaard ME; Southwell AL; Doty CN; Ornelas L; Sahabian A; Lenaeus L; Mandefro B; Sareen D; Arjomand J; Hayden MR; Ross CA; Svendsen CN Hum Mol Genet; 2015 Jun; 24(11):3257-71. PubMed ID: 25740845 [TBL] [Abstract][Full Text] [Related]
5. Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes. Jacquet L; Neueder A; Földes G; Karagiannis P; Hobbs C; Jolinon N; Mioulane M; Sakai T; Harding SE; Ilic D PLoS One; 2015; 10(5):e0126860. PubMed ID: 25993131 [TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310 [TBL] [Abstract][Full Text] [Related]
7. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype. Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255 [TBL] [Abstract][Full Text] [Related]
8. Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics. Akimov SS; Jiang M; Kedaigle AJ; Arbez N; Marque LO; Eddings CR; Ranum PT; Whelan E; Tang A; Wang R; DeVine LR; Talbot CC; Cole RN; Ratovitski T; Davidson BL; Fraenkel E; Ross CA Hum Mol Genet; 2021 Nov; 30(24):2469-2487. PubMed ID: 34296279 [TBL] [Abstract][Full Text] [Related]
9. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys. Cho IK; Yang B; Forest C; Qian L; Chan AWS PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells. Mollica PA; Zamponi M; Reid JA; Sharma DK; White AE; Ogle RC; Bruno RD; Sachs PC J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898922 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303 [TBL] [Abstract][Full Text] [Related]
12. Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease. Rotundo G; Bidollari E; Ferrari D; Spasari I; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Migliore S; Squitieri F; Vescovi AL; Rosati J Stem Cell Res; 2018 May; 29():174-178. PubMed ID: 29704769 [TBL] [Abstract][Full Text] [Related]